DelfaGLP-1 Atlas

Lead sponsor

Carnot Laboratories

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

2

Active

726

Total enrollment

13

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 3
2

Trials by status

Not yet recruiting
2

Trials led

BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 DiabetesBMI ≥27Ph 3Not yet recruiting374
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or ObesityBMI ≥30Ph 3Not yet recruiting352